A. Mert

Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer

A. Mayadağlı, M. Gumus, K. Aydın, 2016, Oncology Research and Treatment.

Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

S. Alıcı, S. Buyukberber, R. Yıldız, 2012, Oncology.

Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment

M. Gumus, U. Kefeli, D. Aydın, 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

M. Gumus, U. Kefeli, D. Aydın, 2013, Clinical and Translational Oncology.

Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy

A. Bilici, U. Kefeli, D. Aydın, 2015, Clinical and Translational Oncology.

Primary/Neoadjuvant Treatments

A. Mert, O. Demir, 2021, Breast Cancer Essentials.

Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients

M. Gumus, D. Aydın, T. Korkmaz, 2016, Tumor Biology.

The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients

M. Gumus, D. Aydın, M. Aliustaoğlu, 2016, Clinical and Translational Oncology.